Year |
Citation |
Score |
2024 |
Gorodetska I, Offermann A, Püschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, Freytag V, Haider MT, Fjeldbo CS, Di Gaetano S, Schwarz FM, Patil S, Borkowetz A, Erb HHH, Baniahmad A, et al. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 14: 714-737. PMID 38169509 DOI: 10.7150/thno.88057 |
0.688 |
|
2021 |
Püschel J, Dubrovska A, Gorodetska I. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells. Cancers. 13. PMID 34572930 DOI: 10.3390/cancers13184703 |
0.669 |
|
2020 |
Peitzsch C, Gorodetska I, Klusa D, Shi Q, Alves TC, Pantel K, Dubrovska A. Metabolic regulation of prostate cancer heterogeneity and plasticity. Seminars in Cancer Biology. PMID 33290846 DOI: 10.1016/j.semcancer.2020.12.002 |
0.722 |
|
2019 |
Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH. Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer. Frontiers in Oncology. 9: 1461. PMID 32038994 DOI: 10.3389/Fonc.2019.01461 |
0.643 |
|
2019 |
Seifert M, Peitzsch C, Gorodetska I, Börner C, Klink B, Dubrovska A. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse. Plos Computational Biology. 15: e1007460. PMID 31682594 DOI: 10.1371/Journal.Pcbi.1007460 |
0.729 |
|
2019 |
Gorodetska I, Kozeretska I, Dubrovska A. Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. Journal of Cancer. 10: 2109-2127. PMID 31205572 DOI: 10.7150/Jca.30410 |
0.649 |
|
2019 |
Gorodetska I, Lukiyanchuk V, Peitzsch C, Kozeretska I, Dubrovska A. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype. International Journal of Cancer. PMID 30968962 DOI: 10.1002/Ijc.32323 |
0.74 |
|
2019 |
Digomann D, Kurth I, Tyutyunnykova A, Chen O, Löck S, Gorodetska I, Peitzsch C, Skvortsova I, Negro G, Aschenbrenner B, Eisenhofer G, Richter S, Heiden S, Porrmann J, Klink B, et al. The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30670494 DOI: 10.1158/1078-0432.Ccr-18-2951 |
0.397 |
|
Show low-probability matches. |